Sign up to save your podcasts
Or
Share Treatment and reinfection risk for hepatitis C treatment: The Lancet Gastroenterology & Hepatology: February 8, 2017
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Treatment and reinfection risk for hepatitis C treatment: The Lancet Gastroenterology & Hepatology: February 8, 2017
Naveed Janjua discusses a study looking at the risk factors associated with hepatitis C reinfection and means to prevent it.
Continue this conversation on social!
Follow us today at...
https://bsky.app/profile/lancetgastrohep.bsky.social
https://www.linkedin.com/company/langastro/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://youtube.com/thelancettv
View all episodes
By The Lancet GroupNaveed Janjua discusses a study looking at the risk factors associated with hepatitis C reinfection and means to prevent it.
Continue this conversation on social!
Follow us today at...
https://bsky.app/profile/lancetgastrohep.bsky.social
https://www.linkedin.com/company/langastro/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://youtube.com/thelancettv
More shows like The Lancet Gastroenterology & Hepatology in conversation with
View all
JAMA Editors' Summary
135 Listeners
American Journal of Gastroenterology Author Podcasts
71 Listeners
JAMA Clinical Reviews
498 Listeners
The Lancet Voice
21 Listeners
The Lancet Child & Adolescent Health in conversation with
0 Listeners
The Lancet Digital Health in conversation with
0 Listeners
The Lancet Global Health in conversation with
2 Listeners
The Lancet Oncology in conversation with
1 Listeners
The Lancet Psychiatry in conversation with
0 Listeners
The Lancet Respiratory Medicine in conversation with
2 Listeners
The Lancet in conversation with
0 Listeners
The Lancet Haematology in conversation with
0 Listeners
The Lancet Diabetes & Endocrinology in conversation with
1 Listeners
The Lancet Infectious Diseases in conversation with
0 Listeners
The Lancet Public Health in conversation with
1 Listeners
The Lancet Microbe in conversation with
0 Listeners
In conversation with...
0 Listeners
eBioMedicine in conversation with
0 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
The Lancet Regional Health in conversation with
0 Listeners
Gastroenterology & Endoscopy
3 Listeners
The Lancet Regional Health Americas in conversation with
0 Listeners
The Lancet Primary Care in conversation with
0 Listeners